AstraZeneca (MEX:AZN1N) E10: MXN58.07 (As of Mar. 2026)


MEX:AZN1N AstraZeneca PLC MEX:AZN1N
84 GF Score
Price MXN3,263.65
GF Value MXN3,171.07
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is AstraZeneca E10?

AstraZeneca MEX:AZN1N 84 E10 is MXN58.07 as of Mar. 2026. GuruFocus rates MEX:AZN1N with a GF Score™ of 84/100 and a GF Value™ of MXN3,171.07 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN35.524. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN58.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, AstraZeneca's average E10 Growth Rate was 16.10% per year. During the past 3 years, the average E10 Growth Rate was 16.40% per year. During the past 5 years, the average E10 Growth Rate was 5.20% per year. During the past 10 years, the average E10 Growth Rate was -3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of AstraZeneca was 77.50% per year. The lowest was -26.20% per year. And the median was 1.90% per year.

As of today (2026-07-03), AstraZeneca's current stock price is MXN3263.65. AstraZeneca's E10 for the quarter that ended in Mar. 2026 was MXN58.07. AstraZeneca's Shiller PE Ratio of today is 56.20.

During the past 13 years, the highest Shiller PE Ratio of AstraZeneca was 75.22. The lowest was 15.48. And the median was 41.74.


AstraZeneca  (MEX:AZN1N) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3263.65/58.07
=56.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of AstraZeneca was 75.22. The lowest was 15.48. And the median was 41.74.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


AstraZeneca E10 Related Terms


AstraZeneca E10 Historical Data

* Premium members only.

The historical data trend for AstraZeneca's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca E10 Chart

AstraZeneca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 32.73 36.89 61.72 59.37

AstraZeneca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.20 64.35 59.66 59.37 58.07

MEX:AZN1N vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.


MEX:AZN1N
84GF Score
AstraZeneca PLC MEX:AZN1N
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AstraZeneca E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=35.524/140.8000*140.8000
=35.524

Current CPI (Mar. 2026) = 140.8000.

AstraZeneca Quarterly Data

per share eps CPI Adj_EPS
201606 -0.044 101.000 -0.061
201609 15.468 101.500 21.457
201612 29.895 102.200 41.186
201703 7.908 102.700 10.842
201706 6.869 103.500 9.344
201709 9.800 104.300 13.230
201712 20.229 105.000 27.126
201803 4.905 105.100 6.571
201806 5.305 105.900 7.053
201809 6.360 106.600 8.400
201812 16.101 107.100 21.167
201903 9.117 107.000 11.997
201906 1.729 107.900 2.256
201909 4.541 108.400 5.898
201912 4.526 108.500 5.873
202003 13.834 108.600 17.936
202006 13.388 108.800 17.326
202009 10.825 109.200 13.958
202012 15.516 109.400 19.969
202103 24.120 109.700 30.958
202106 8.361 111.400 10.568
202109 -22.618 112.400 -28.333
202112 -4.513 114.700 -5.540
202203 4.978 116.500 6.016
202206 4.627 120.500 5.406
202209 21.121 122.300 24.316
202212 11.308 125.300 12.707
202303 20.909 126.800 23.218
202306 20.058 129.400 21.825
202309 15.329 130.100 16.590
202312 10.524 130.500 11.355
202403 23.235 131.600 24.859
202406 22.717 133.000 24.049
202409 17.918 133.500 18.898
202412 20.021 135.100 20.866
202503 38.257 136.100 39.578
202506 29.562 138.400 30.075
202509 29.718 138.900 30.125
202512 26.828 139.900 27.001
202603 35.524 140.800 35.524

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN58.07 mean?
AstraZeneca (MEX:AZN1N) has a E10 of MXN58.07 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AstraZeneca and its competitors.
Is AstraZeneca's E10 too high?
AstraZeneca's current E10 is MXN58.07. Overall, AstraZeneca has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca's E10 compare to LLY and JNJ?
AstraZeneca's E10 of MXN58.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on AstraZeneca and its competitors. AstraZeneca's current E10 is MXN58.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca stock overvalued right now?
Based on GuruFocus' analysis, AstraZeneca (MEX:AZN1N) is currently considered Fairly Valued. The stock's GF Value™ is MXN3,171.07, compared to a current price of MXN3,263.65 — trading 2.9% above its estimated fair value. The current E10 is MXN58.07. AstraZeneca's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For AstraZeneca (MEX:AZN1N), the current E10 is MXN58.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AstraZeneca (MEX:AZN1N) Overvalued in 2026?

Based on GuruFocus' analysis, AstraZeneca stock appears to be overvalued. The current stock price of MXN3,263.65 is trading 2.9% above its estimated GF Value™ of MXN3,171.07. GuruFocus considers AstraZeneca to be Fairly Valued.

Key valuation signals for MEX:AZN1N:

  • E10: MXN58.07
  • GF Value™: MXN3,171.07 vs. price of MXN3,263.65 (2.9% above fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the MEX:AZN1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AstraZeneca Business Description

Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
84GF Score

Get the complete analysis for MEX:AZN1N

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,263.65
Price
MXN3,171.07
GF Value